Category: Technology

Miami-Based Reputation Firm Earns Prestigious Recognition from One of the UK’s Most Trusted News Publications

LONDON, ENGLAND, UNITED KINGDOM, March 4, 2026 /EINPresswire.com/ — Reputation Pros, a leading online reputation management firm founded by digital marketing authority Scott Keever, has been recognized by The Independent as one of the Top Online Reputation Management Firms Serving the UK in 2026. The recognition, featured in The Independent’s business coverage at independent.co.uk, underscores Reputation Pros’ growing global footprint and its proven track record of delivering measurable results for clients on both sides of the Atlantic.

The Independent, one of the United Kingdom’s most widely read and respected news platforms, evaluated firms based on their methodologies, client results, industry reputation, and ability to serve UK-based individuals and organizations. Reputation Pros earned its placement on the strength of its precision-driven suppression campaigns, proactive brand-building strategies, and deep expertise navigating the intersection of Google’s evolving search algorithms and generative AI platforms.

“Being recognized by The Independent is a meaningful validation of what our team builds every day: reputation strategies that are ethical, durable, and designed to win in an AI-driven search landscape. The UK market is a priority for us, and this recognition reflects the results we’ve delivered for executives, brands, and professionals across the globe.”

Scott Keever, Founder & CEO, Reputation Pros

Reputation Pros has built its reputation on a methodology that goes beyond reactive content suppression. The firm employs a comprehensive approach combining high-authority content creation, strategic link building, entity optimization, and AI-ready brand signals to help clients build lasting credibility across Google Search, Google News, and emerging AI discovery platforms. This forward-looking philosophy has positioned Reputation Pros as a trusted partner for CEOs, public figures, law firms, medical professionals, and enterprise brands facing high-stakes reputational challenges.

The recognition by The Independent adds to a growing list of industry accolades for Reputation Pros, which has previously been cited by Forbes, Manchester Digital, Barchart, and numerous top-tier publications as one of the best online reputation management companies. The firm’s work has been particularly noted for its success in complex, high-visibility cases where speed, discretion, and sustainable results are paramount.

As the UK continues to see rising demand for professional reputation services driven by increased public scrutiny, evolving data privacy regulations, and the growing influence of AI-generated search results, Reputation Pros is uniquely positioned to serve clients requiring a global-caliber firm with nuanced expertise in the UK digital landscape.

About Reputation Pros

Reputation Pros is a Miami-based online reputation management firm founded by Scott Keever, a Forbes Agency Council member, Fast Company Executive Board member, and bestselling author of Reputation Reset and Future-Proof Your SEO. The firm specializes in helping executives, public figures, and global brands control their digital narrative through ethical, Google-compliant strategies that suppress negative content, promote authoritative positive assets, and build long-term trust across search and AI platforms. Learn more at reputationpros.com.

About Scott Keever

Scott Keever is a Miami-based digital marketing entrepreneur, bestselling author, and online reputation management authority. Born on January 15, 1981, in Lebanon, Ohio, Keever attended Miami University before building one of the most recognized portfolios of digital marketing companies in the United States.
Keever is the founder and CEO of Reputation Pros, a leading online reputation management firm trusted by executives, public figures, and global brands to manage and restore their digital credibility. He is also the founder and CEO of Keever SEO, a nationally recognized search engine optimization agency, as well as ASAP Digital Marketing and Pool Pros Marketing.

Scott Keever is a Forbes Agency Council member, a Fast Company Executive Board member, and an Entrepreneur Leadership Network contributor. He is the bestselling author of two books: Reputation Reset and Future-Proof Your SEO, both of which reflect his expertise at the intersection of search engine optimization, brand authority, and online reputation management.

Keever is widely known in the SEO industry for his long-running demonstration of search dominance, having maintained the number one Google ranking for the phrase “Best Looking Guy in Miami” for over a decade. This case study has been cited across numerous publications as proof of his technical SEO capabilities.

Scott Keever and his companies have been featured in Forbes, Fast Company, The Independent, Manchester Digital, Barchart, and other top-tier outlets. His work focuses on helping clients build durable digital authority across Google Search, Google News, and AI-driven discovery platforms.

Scott Keever
Reputation Pros
+1 813-455-1455
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

OmniMD introduces a unified AI-powered clinical–financial platform delivering predictive revenue insights, automation, and real-time performance visibility.

HAWTHORNE, NY, UNITED STATES, March 5, 2026 /EINPresswire.com/ — Healthcare revenue integrity remains a systemic challenge in the U.S., driven by elevated claim denial rates, fragmented financial workflows, and administrative inefficiencies that can divert clinical resources from patient care. Industry analyses show that initial claim denials hover around 11.8% nationally, creating ongoing operational friction for providers.

In response, OmniMD today introduces a unified clinical–financial operating architecture designed to transform revenue performance through native data integration and advanced artificial intelligence (AI). The platform reconceptualizes revenue cycle operations as a predictive, real-time continuum of healthcare delivery rather than a lagging post-encounter reconciliation function.

𝐐𝐮𝐚𝐧𝐭𝐢𝐟𝐢𝐚𝐛𝐥𝐞 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐈𝐦𝐩𝐞𝐫𝐚𝐭𝐢𝐯𝐞𝐬

Contemporary benchmarks in claims performance underscore the scale of financial leakage and operational strain within healthcare administration:

• Initial denial rates exceed 10%, with rework costs per denied claim estimated up to $25 each, increasing resource utilization and delaying cash flow.

• Top performing practices are defined by a 98% clean claim rate, indicating near-error-free submissions on first pass.

• The U.S. revenue cycle management market is substantial and expanding, estimated above USD 170 billion in 2024 and forecast to grow at over 10% compound annual growth.

These metrics reflect systemic pressures on financial operations and substantiate the clinical and economic value of structural revenue intelligence.

𝐀 𝐒𝐢𝐧𝐠𝐥𝐞 𝐍𝐚𝐭𝐢𝐯𝐞 𝐀𝐫𝐜𝐡𝐢𝐭𝐞𝐜𝐭𝐮𝐫𝐞 𝐟𝐨𝐫 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐚𝐧𝐝 𝐅𝐢𝐧𝐚𝐧𝐜𝐢𝐚𝐥 𝐀𝐥𝐢𝐠𝐧𝐦𝐞𝐧𝐭

OmniMD’s operating platform integrates Electronic Health Record (EHR), Practice Management (PM), Revenue Cycle Management (RCM), Interoperability, and AI-enabled workflow engines within a single, natively connected system. This cohesion addresses fundamental causes of administrative leakage by eliminating data fragmentation and enabling real-time operational insights.

Key architectural innovations include:

• 𝗡𝗮𝘁𝗶𝘃𝗲 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹-𝗙𝗶𝗻𝗮𝗻𝗰𝗶𝗮𝗹 𝗜𝗻𝘁𝗲𝗴𝗿𝗮𝘁𝗶𝗼𝗻: Clinical documentation influences billing and coding logic at the point of care, minimizing downstream corrections.

• 𝗔𝗜-𝗗𝗿𝗶𝘃𝗲𝗻 𝗣𝗿𝗲𝗱𝗶𝗰𝘁𝗶𝘃𝗲 𝗔𝗻𝗮𝗹𝘆𝘁𝗶𝗰𝘀: Pattern recognition models anticipate payer behavior and flag potential denial risks pre-submission.

• 𝗥𝗲𝗮𝗹-𝗧𝗶𝗺𝗲 𝗘𝗹𝗶𝗴𝗶𝗯𝗶𝗹𝗶𝘁𝘆 𝗮𝗻𝗱 𝗖𝗵𝗮𝗿𝗴𝗲 𝗩𝗮𝗹𝗶𝗱𝗮𝘁𝗶𝗼𝗻: Automated verification reduces manual rework and accelerates payment cycles.

By integrating these capabilities within one environment, the platform supports continuous performance optimization rather than episodic corrections.

𝐀𝐝𝐯𝐚𝐧𝐜𝐢𝐧𝐠 𝐑𝐞𝐯𝐞𝐧𝐮𝐞 𝐈𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐜𝐞 𝐓𝐡𝐫𝐨𝐮𝐠𝐡 𝐌𝐚𝐜𝐡𝐢𝐧𝐞 𝐋𝐞𝐚𝐫𝐧𝐢𝐧𝐠

OmniMD applies AI across structured and unstructured clinical data using scalable models that prioritize accuracy and workflow augmentation. Predictive analytics identify emergent trends in claim risk, enabling intervention ahead of payer adjudication.

Contemporary health system research highlights the efficacy of AI-augmented denial management and AI claim scrubbing to reduce error rates prior to submission, an advance that aligns with national calls for automation in revenue cycle processes.

The platform’s intelligence layer is engineered to work across clinical documentation, payer rule sets, eligibility verification, and accounts receivable, providing performance visibility at every stage of the encounter continuum.

𝐂𝐨𝐦𝐩𝐥𝐢𝐚𝐧𝐜𝐞-𝐀𝐧𝐜𝐡𝐨𝐫𝐞𝐝 𝐈𝐧𝐟𝐫𝐚𝐬𝐭𝐫𝐮𝐜𝐭𝐮𝐫𝐞 𝐚𝐧𝐝 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐀𝐜𝐜𝐨𝐮𝐧𝐭𝐚𝐛𝐢𝐥𝐢𝐭𝐲

As reimbursement models evolve and regulatory expectations intensify, OmniMD’s architecture centralizes governance and compliance monitoring. The unified data environment supports audit-ready documentation and standardized workflows, enhancing operational trust and financial transparency.

The platform’s infrastructure is designed for scalability, supporting multi-location clinics, ambulatory networks, virtual care modalities, and remote patient monitoring without disparate third-party integrations or manual mediation layers.

𝐃𝐞𝐟𝐢𝐧𝐢𝐧𝐠 𝐚 𝐍𝐞𝐰 𝐂𝐚𝐭𝐞𝐠𝐨𝐫𝐲 𝐨𝐟 𝐑𝐞𝐯𝐞𝐧𝐮𝐞 𝐏𝐞𝐫𝐟𝐨𝐫𝐦𝐚𝐧𝐜𝐞

OmniMD situates itself not as a labor-based billing service but as an AI-enabled healthcare operating platform. This category is characterized by:

• Deep integration of clinical and financial systems

• Real-time, predictive revenue insights

• Scalable automation across documentation and claims lifecycles

• Compliance-grade operational governance

This architecture reframes financial operations as a data-driven performance function rather than a cost center.

𝐋𝐞𝐚𝐝𝐞𝐫𝐬𝐡𝐢𝐩 𝐒𝐭𝐚𝐭𝐞𝐦𝐞𝐧𝐭

“Achieving financial integrity in healthcare requires a fundamentally different systems architecture,” said 𝐃𝐢𝐯𝐚𝐧 𝐃𝐚𝐯𝐞, 𝐂𝐄𝐎, 𝐎𝐦𝐧𝐢𝐌𝐃. “OmniMD’s platform is engineered to integrate clinical care delivery with financial accountability, enabling organizations to act on operational intelligence instead of reacting to revenue leakage.”

𝐀𝐛𝐨𝐮𝐭 𝐎𝐦𝐧𝐢𝐌𝐃

OmniMD is a technology-centric healthcare operating platform that integrates clinical documentation, revenue performance workflows, interoperability standards, and AI-driven process intelligence within one native architecture. The platform is designed to enable quantifiable revenue performance, compliance assurance, and scalable operational excellence across diverse healthcare organizations.

Divan Dave
OmniMD
+1 844-666-4631
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube
X

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

ROLEC has expanded its handCASE line of handheld enclosures, offering new options for applications in machine control, robotics, and defense electronics.

BRIDGEVILLE, PA, UNITED STATES, March 5, 2026 /EINPresswire.com/ — The enclosures, rated IP66/IP67, are designed for use in demanding industrial and military environments where handheld devices must remain durable and comfortable to operate.

The handCASE series is now available with a choice of two lid styles and optional battery compartments supporting either four AA cells or two 9 V batteries. Version S features an ergonomically beveled lid, while Version R incorporates a narrow-edged lid to increase internal space. Both versions include recessed top surfaces that help protect membrane keypads or front plates. Internal threaded screw bosses support the installation of PCBs or mounting plates.

Three enclosure sizes are offered:

* 3.15″ × 7.09″ × 1.67″
* 3.94″ × 8.66″ × 1.67″
* 3.94″ × 8.66″ × 2.46″

Standard finishes include a black (RAL 9005) base with a silver metallic top for Version S, and a full light gray (RAL 7035) finish for Version R.

Custom color options are available on request, including weather‑resistant powder coatings with WIWeB approvals and camouflage finishes suitable for military use. These coatings are also offered in wet‑paint variants and meet military requirements such as the VG 95211 defense equipment standard.

Available accessories include a shoulder strap, a holding clip with wall bracket, and a corrosion‑resistant coating in azure blue (RAL 5009).

ROLEC provides customization services for the handCASE series, including CNC machining, engraving, RFI/EMI shielding, screen and digital printing, and accessory assembly.

Learn more about handCASE here >>

SEAN J BAILEY
ROLEC Enclosures Inc
+1 888-658-5774
email us here

ROLEC handCASE Diecast Handheld Enclosures

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

The partnership connects structured clinical data with EHR workflows to accelerate referrals, care coordination, and time to treatment

OAKLAND, CA, UNITED STATES, March 5, 2026 /EINPresswire.com/ — xCures, an AI-enabled healthcare data platform that extracts and structures clinical information from medical records and makes AI-ready outputs available through a platform UI and standard REST APIs, today announced a partnership with careMESH, a healthcare technology company delivering EHR-integrated referral management and care coordination solutions.

Through the partnership, healthcare organizations will be able to combine xCures’ structured clinical data and APIs with careMESH’s EHR-native workflow platform, helping care teams streamline referral intake, improve clinical visibility, and reduce administrative friction across care coordination.

The collaboration enables healthcare organizations to integrate xCures’ normalized clinical data directly into careMESH’s referral management and coordination workflows within the EHR. The result is a more seamless path from medical record retrieval to clinical action, reducing manual processes and accelerating time to treatment.

“Both teams are focused on practical interoperability, getting the right clinical information to the right stakeholders, reliably and in context,” said Mika Newton, CEO of xCures. “This partnership is designed to help customers reduce friction across medical record retrieval, normalization, and downstream clinical workflows.”

“careMESH is designed to manage referrals and care coordination directly within the EHR, embedding workflow, communication, and secure access into the daily flow of care,” said Peter S. Tippett, MD, PhD, CEO of careMESH. “By integrating xCures’ structured clinical data into our platform, we can help organizations reduce friction in referral intake, improve workflow visibility, and accelerate time to treatment, all while reducing burden to clinicians or IT teams.”

The companies expect to collaborate on initial customer-facing use cases and, over time, expand integration opportunities as healthcare organizations increasingly seek interoperable platforms that combine clinical data access with embedded workflow tools.

About xCures^®
Founded in 2018, xCures operates an AI-enabled healthcare data platform that serves as the semantic layer for healthcare data. It rapidly extracts high-quality information from medical records collected from a wide variety of sources.

The platform gives healthcare organizations fast, reliable access to the clinical data elements they need, when they need them, to make informed decisions. For more information, contact info@xcures.com or visit www.xcures.com

About careMESH
careMESH delivers EHR-integrated referral management and care coordination solutions that embed workflow, communication, provider directory and provider connectivity directly into clinical systems. careMESH enables hospitals, oncology, cardiology and other care teams to streamline referral intake, reduce manual processes, improve handoffs, and accelerate time to treatment, all while reducing costs and often improving revenue. For more information, visit www.caremesh.com.

Patrick van der Valk
xCures Inc
email us here

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Principled Technologies (PT) compared the 5-year TCO of the two solutions and saw that the Dell solution could cost up to 38% less.

ROUND ROCK, TX, UNITED STATES, March 5, 2026 /EINPresswire.com/ — Organizations pursuing GenAI initiatives have a range of challenges to contend with, but cost is a significant issue. To plan and budget properly, leaders investing in GenAI platforms need to understand what these solutions will cost over time.

Principled Technologies assessed the five-year total cost of ownership (TCO) of two solutions for GenAI workloads: Dell AI Factory with NVIDIA, utilizing Red Hat OpenShift, and an equivalent AWS SageMaker solution. PT looked at the cost of the Dell and NVIDIA solution both as a traditional on-premises solution, which an organization might buy outright, and as a subscription transacting through Dell APEX Infrastructure.

The report states, “Our analysis found that over a five-year period, the Dell AI Factory with NVIDIA solutions would be substantially more cost-effective than the AWS solution, reducing TCO by 33 percent when transacting through Dell APEX Infrastructure and 38 percent for a CAPEX payment. Plus, by including Red Hat OpenShift licenses, the Dell AI Factory solution builds in additional functionality to accelerate AI apps while still saving money over the life of the solution. Deploying GenAI on-premises with a Dell AI Factory with NVIDIA solution, utilizing Red Hat OpenShift, can help make your GenAI project a success.”

It concludes, “Organizations looking to advance their AI initiatives can face significant challenges around cost management, solution selection, and operational efficiency. The on-premises Dell AI Factory with NVIDIA solution utilizing Red Hat OpenShift addresses these concerns by offering a cost-effective infrastructure for GenAI. Additionally, the trusted Red Hat OpenShift Container Platform provides a platform for cloud-native apps that integrates with Dell and NVIDIA hardware to help organizations start transforming business operations quickly. Our research shows that the Dell AI Factory with NVIDIA solution—either purchased upfront or transacting through Dell APEX Infrastructure—can save organizations up to 38 percent over hosting on AWS SageMaker.”

Read the report at https://facts.pt/miHUul6 to learn more about how organizations can save money over five years with a Dell AI Factory with NVIDIA solution.

About Principled Technologies, Inc.
Principled Technologies, Inc. is the leading provider of technology marketing and learning & development services.

Principled Technologies, Inc. is located in Durham, North Carolina, USA. For more information, please visit www.principledtechnologies.com.

Sharon Horton
Principled Technologies, Inc.
press@principledtechnologies.com
Visit us on social media:
LinkedIn
Facebook
YouTube
X

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

CINCINNATI, OH, UNITED STATES, March 5, 2026 /EINPresswire.com/ — Synchrocare, LLC, a U.S. medical device distributor founded in 2005, announced today a new strategic distribution partnership with BioPoly, an orthopedic biomaterials company focused on polymer-based implant solutions. Under the agreement, Synchrocare will distribute BioPoly’s products nationwide, expanding surgeons’ access to implant technology designed to provide strength, durability, and long-term biocompatibility.

BioPoly develops and manufactures polymer implants engineered as alternatives to traditional metal implants in certain orthopedic procedures. The company’s proprietary material platform is designed to support mechanical performance while reducing wear on opposing cartilage compared to traditional metal implants, offering surgeons additional options when selecting implants for their patients.

Through the partnership, Synchrocare will serve as a national distribution partner for BioPoly’s product portfolio, leveraging its established sales, service, and clinical infrastructure to support surgeons and healthcare facilities across the United States.

“We developed our polymer technology to address real challenges associated with traditional implant materials,” said Herb Schwartz, PhD, President and CEO of BioPoly. “Partnering with Synchrocare gives us a national distribution platform with the clinical support infrastructure needed to bring our technology to more surgeons and healthcare facilities across the country. We are pleased to work with a team that shares our commitment to consistency, compliance, and surgeon support.”

As part of the collaboration, Synchrocare will provide sales, service, and clinical support for BioPoly’s products, working alongside healthcare providers to support appropriate use and product familiarity. Synchrocare conducts all distribution and support activities in accordance with applicable regulations and industry standards.

“Synchrocare is focused on providing healthcare practitioners with access to innovative, well-designed medical devices,” said Reza Yazdian, J.D., Principal Managing Partner of Synchrocare.

The partnership reflects Synchrocare’s continued strategy of working with medical device manufacturers whose technologies complement its existing portfolio and meet the needs of surgeons and healthcare facilities nationwide.

About BioPoly
BioPoly is a U.S.-based orthopedic biomaterials company focused on the development and manufacturing of polymer implant technologies. The company is committed to supporting surgeons through dependable products designed for clinical use. More information is available at www.biopolyortho.com.

About Synchrocare, LLC
Founded in 2005, Synchrocare, LLC is a U.S. distributor of medical devices with a growing national footprint. The company partners with medical device manufacturers to support surgeons and healthcare facilities with high-quality products, clinical support, and responsive service.

Contact:
For more information or to arrange an interview, please contact info@synchrocare.com or visit www.synchrocare.com.

Reza Yazdian, J.D.
Synchrocare, LLC
+1 877-238-0317
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube
X

Partner with Synchrocare

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.